Left ventricular systolic function during stress echocardiography exercise in subjects with asymptomatic hereditary

Yukitaka Shizukuda1, Charles D Bolan, Dorothy J Tripodi

  • 1Cardiovascular Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA. shizukuy@nhlbi.nih.gov

Insights

Asymptomatic individuals with hereditary hemochromatosis (HH) maintain normal left ventricular (LV) systolic function during exercise. Iron removal therapy did not alter stress echocardiography performance in these patients.

Area of Science:

  • Cardiology
  • Genetics
  • Internal Medicine

Background:

  • Hereditary hemochromatosis (HH) is a genetic disorder of iron overload.
  • Left ventricular (LV) systolic function in asymptomatic HH patients is not well-understood.
  • Stress echocardiography is a key tool for assessing cardiac function under stress.

Purpose of the Study:

  • To evaluate left ventricular (LV) systolic function and stress echocardiography response in asymptomatic subjects with hereditary hemochromatosis (HH).
  • To compare cardiac function between untreated HH, treated HH, and healthy controls.
  • To assess the impact of iron removal therapy on cardiac function in HH patients.

Main Methods:

  • Compared 43 asymptomatic HH patients (22 untreated, 21 treated) with 21 healthy controls.
  • Assessed LV contractile reserve using continuous echocardiography and ECG during supine bicycle exercise.
  • Nineteen untreated HH patients underwent repeat testing after 6 months of phlebotomy therapy.

Main Results:

  • LV contractile reserve was preserved in asymptomatic HH patients at submaximal and peak exercise.
  • No significant difference in LV ejection fraction response was observed between HH groups and controls.
  • Abnormal ischemic stress ECG responses were more frequent in HH patients (33%) than controls (10%), likely false positives.

Conclusions:

  • Left ventricular (LV) systolic function during exercise is preserved in asymptomatic hereditary hemochromatosis (HH) patients.
  • Stress echocardiography performance is not affected by 6-month iron removal therapy via phlebotomy.
  • Abnormal stress ECG findings in HH patients warrant further investigation to differentiate from true ischemia.